The BHF contributes to multiple research consortiums with other funding partners. We aim to add value to the overall national or international research landscape.
Below is a list of projects that we have supported.
Health Data Research UK
BHF contributed £2m in 2017/18 towards the establishment of Health Data Research UK (HDRUK).
This project was part of an overall award worth £52.75m made by 10 funders in total.
HDRUK’s goal is to use cutting edge data science approaches on health and biomedical data. To address the most important health research challenges.
UK Prevention Research Partnership
BHF contributed £3m in 2017/18 towards the UK Prevention Research Partnership.
This was an alliance of research funders pooling resources worth £40m - £50m. To support research into the prevention of non-communicable diseases.
UK Biobank
BHF has made several awards to UK Biobank. A large long-term health resource to support research into the prevention, diagnosis and treatment of a range of diseases.
- 2007/2008: £1m towards biomarker development in UK Biobank.
- 2009/2010: £1m towards enhancements within the Biobank.
- 2012/2013: £1m awarded of a total grant of £9.3m for improved biomarker development. Joint-funded with Wellcome Trust, MRC and Diabetes UK.
- 2015/2016: £3m awarded of a total grant of £33m for imaging studies in UK Biobank. Joint-funded with Wellcome Trust and MRC.
- 2017/2018: £3.17m awarded of a total grant of £31.7m. For core renewal of the UK Biobank until 2022. Joint-funded with Wellcome Trust and MRC.
European Research Area (ERA) Network on Cardiovascular Diseases
The European Research Area Network on Cardiovascular Diseases supports transnational calls for cardiovascular research across the European Research Area.
- 2016/17: Professor Manuel Mayr, King’s College London, SP/17/10/33219.
Non-coding RNAs in cardiac macrophages and their role in heart failure. BHF awarded £249,492 over 3 years.
- 2016/17: Dr Thomas Webb, University of Leicester, SP/18/8/33620.
Druggable MI genes: utilising myocardial infarction genes for better treatment. BHF awarded £249,829 over 3 years.